Clinical trials
Recruiting Prediabetic State trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Anzhen Hospital | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Eli Lilly and Company | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Hudson Biotech | 1 |
| Shandong University | 1 |
| Shanghai Municipal Hospital of Traditional Chinese Medicine | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Yang Zhang | 1 |
| Zhujiang Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 10 |
| Obesity | 4 |
| Overweight | 3 |
| Diabetes Mellitus | 2 |
| Obesity, Abdominal | 2 |
| Prehypertension | 2 |
| Diabetes, Gestational | 1 |
| Insulin Resistance | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.